Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Freeline Therapeutics

    NASDAQ: FRLN · Real-Time Price · USD
    6.49
    0.01 (0.15%)
    At close: Feb 16, 2024, 9:37 PM

    Freeline Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -88.97M -140.39M
    Depreciation & Amortization
    		 1.74M 2.39M
    Stock-Based Compensation
    		 5.08M 10.72M
    Other Working Capital
    		 3.62M 22.54M
    Other Non-Cash Items
    		 -4.98M 148K
    Deferred Income Tax
    		 -156K -171K
    Change in Working Capital
    		 9.07M 19.74M
    Operating Cash Flow
    		 -78.22M -107.56M
    Capital Expenditures
    		 -7.01M -4.27M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 -7.01M -4.27M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 27.52M -984K
    Financial Cash Flow
    		 27.52M -984K
    Net Cash Flow
    		 -70.46M -112.51M
    Free Cash Flow
    		 -85.24M -111.83M

    Add to Watchlist